TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling

Breast cancer (BC) is the most common female malignancy worldwide, and 70% of which are estrogen receptor α (ERα) positive. Endocrine treatment, such as tamoxifen, is a primary adjuvant therapy for patients with ER-positive BC. However, some patients will develop acquired resistance following long-t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Tian, Zelin, Tang, Jianing, Liao, Xing, Gong, Yan, Yang, Qian, Wu, Yumin, Wu, Gaosong
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7642662/
https://ncbi.nlm.nih.gov/pubmed/33163282
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars